bupivacaine has been researched along with ginkgolide b in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cheung, CW; Lai, LY; Li, L; Wen, XJ; Xu, SY; Zhang, QG; Zheng, T; Zhou, SQ | 1 |
3 other study(ies) available for bupivacaine and ginkgolide b
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Neuroprotective effect of ginkgolide B on bupivacaine-induced apoptosis in SH-SY5Y cells.
Topics: Apoptosis; Bupivacaine; Caspase 12; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Electron Transport Complex I; Electron Transport Complex III; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Enzyme Activation; Flow Cytometry; Ginkgolides; Heat-Shock Proteins; High-Temperature Requirement A Serine Peptidase 2; Humans; Lactones; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Proteins; Neuroprotective Agents; Reactive Oxygen Species; RNA, Messenger; Serine Endopeptidases | 2013 |